Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 251-275 of 917 matching filings.

Per page
25
Current page
11
4

4 filing

Filing date
16 Mar 2020
Reporting date
15 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-56243

SC 13D/A

Filing date
13 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-31326

FORM 8-K/A

Filing date
13 Mar 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-236952

FORM S-8

Filing date
06 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
04 Mar 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
04 Mar 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
04 Mar 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
04 Mar 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2020
Reporting date
25 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2020
Reporting date
25 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56243

SC 13G/A

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
14 Jan 2020
Reporting date
14 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Dec 2019
Reporting date
26 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Sep 2019
Reporting date
26 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .